|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-4-14
|
|
pubmed:abstractText |
The purpose of this study was to determine the feasibility of a new positron emission tomography (PET) imaging approach using an (18)F-labelled alpha(v)beta(3) integrin antagonist ((18)F-Galacto-RGD) to monitor the integrin expression after myocardial infarction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0008-6363
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
395-403
|
|
pubmed:meshHeading |
pubmed-meshheading:18256073-Animals,
pubmed-meshheading:18256073-Antigens, CD31,
pubmed-meshheading:18256073-Autoradiography,
pubmed-meshheading:18256073-Coronary Vessels,
pubmed-meshheading:18256073-Disease Models, Animal,
pubmed-meshheading:18256073-Feasibility Studies,
pubmed-meshheading:18256073-Galactose,
pubmed-meshheading:18256073-Immunohistochemistry,
pubmed-meshheading:18256073-Integrin alphaVbeta3,
pubmed-meshheading:18256073-Male,
pubmed-meshheading:18256073-Myocardial Infarction,
pubmed-meshheading:18256073-Myocardium,
pubmed-meshheading:18256073-Neovascularization, Physiologic,
pubmed-meshheading:18256073-Peptides, Cyclic,
pubmed-meshheading:18256073-Positron-Emission Tomography,
pubmed-meshheading:18256073-Radiopharmaceuticals,
pubmed-meshheading:18256073-Rats,
pubmed-meshheading:18256073-Rats, Wistar,
pubmed-meshheading:18256073-Time Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography.
|
|
pubmed:affiliation |
Nuklearmedizinische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger Strasse 22, 81675 Munich, Germany. higuchi@po2.nsknet.or.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
